Pharmacokinetics of Ketamine in Infants and Children

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
The Pk of IV Ketamine in Children With Heart Disease
Interventions
DRUG

ketamine hydrochloride

Open label pharmacokinetic study to be conducted in infants and children presenting for medical procedures (eg., surgery or cardiac catheterization). After the start of the procedure, a 0.5 cc preload blood sample (T0) will be drawn from an IV line. Then a 2 mg/kg IV bolus of Ketamine will be administered over 5 minutes. Timed 0.5 ml blood samples will be drawn at the following intervals: 5, 10, 15, 20, 30, 45, 60, 120, 180, 240, 300, 360 and 720 minutes after bolus.

Trial Locations (2)

80218

The Children's Hospital, Denver

94304

Lucile Packard Children's Hospital, Palo Alto

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

Stanford University

OTHER

NCT00553839 - Pharmacokinetics of Ketamine in Infants and Children | Biotech Hunter | Biotech Hunter